
Current Operational Subsidiaries
JMN Brothers Pharma Limited Inc.
JMN Brothers Pharma Limited, Inc., a subsidiary company of Delex Pharma, was founded in the Philippines on June 27, 2016, by the management heading the latter organization. Although it is a new player in the market, it has slowly made rounds to become one of the trusted companies in the country, focusing on women’s health and ethical products.
While JMN Pharma strives to bring premier and affordable pharmaceutical products to the Philippine market, it has forged partnerships with credible WHO-GMP-compliant local and multinational manufacturing companies. Hence, it boosts the highest ethical standard of the company in the pharmaceutical field. Moreover, the various Intensive Care Unit (ICU) medicines, multivitamin, and food supplement it markets are duly licensed by the Philippine Food and Drug Administration (FDA). These assure the utmost safety of the market.
DLX Holdings Corp.
DLX Holdings Corp., (DLX) the subsidiary of our company, was registered in December 2012, and is the parent company of Delex Pharma International Inc. (DPI). DLX is engaged in the development, distribution and trading of medical supplies, equipment, pharmaceutical products, and food supplements.
Delex Pharma International Inc.
Delex Pharma International, Inc. (DPI), a socially accountable Filipino-owned and ISO 9001:2015-certified company, has continuously served its nationwide market for fourteen years. The company is 60% owned by DLX Holdings, Inc. and 40% owned by High Everest Capital Inc.